Lumos Pharma, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
JPMORGAN CHASE & CO | 02/12/2025 | 0 | $0 | -100.00% | 0.00% |
WELLS FARGO & COMPANY/MN | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
STATE STREET CORP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
JEFFERIES FINANCIAL GROUP INC. | 02/27/2025 | 0 | $0 | -100.00% | 0.00% |
VANGUARD GROUP INC | 02/11/2025 | 0 | $0 | -100.00% | 0.00% |
DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
JONES FINANCIAL COMPANIES LLLP | 02/06/2025 | 0 | $0 | -100.00% | 0.00% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 0 | $0 | -100.00% | 0.00% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 0 | $0 | -100.00% | 0.00% |
BANK OF NEW YORK MELLON CORP | 02/04/2025 | 0 | $0 | -100.00% | 0.00% |
GREENWICH WEALTH MANAGEMENT LLC | 02/10/2025 | 0 | $0 | -100.00% | 0.00% |
TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
PRIVATE ADVISOR GROUP, LLC | 02/03/2025 | 0 | $0 | -100.00% | 0.00% |
UBS GROUP AG | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
LION POINT CAPITAL, LP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
KEY FINANCIAL INC | 01/31/2025 | 0 | $0 | -100.00% | 0.00% |
WEALTH ADVISORS OF IOWA, LLC | 02/11/2025 | 0 | $0 | -100.00% | 0.00% |
LIVE OAK INVESTMENT PARTNERS | 02/06/2025 | 0 | $0 | -100.00% | 0.00% |
WEST FINANCIAL ADVISORS, LLC | 01/14/2025 | 0 | $0 | -100.00% | 0.00% |
PALADIN ADVISORY GROUP, LLC | 01/23/2025 | 0 | $0 | -100.00% | 0.00% |
ADAR1 CAPITAL MANAGEMENT, LLC | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 0 | $0 | -100.00% | 0.00% |
Lumos Pharma, Inc. institutional Ownership - FAQ's
During the previous two years, 35 institutional investors and hedge funds held shares of Lumos Pharma, Inc.. The most heavily invested institutionals were:
JONES FINANCIAL COMPANIES LLLP: 0
VANGUARD GROUP INC: 0
UBS Group AG: 0
GOLDMAN SACHS GROUP INC: 0
Live Oak Investment Partners: 0
GEODE CAPITAL MANAGEMENT, LLC: 0
0.00% of Lumos Pharma, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 200,349 shares in the last 24 months. This purchase volume represents approximately $869,515 in transactions.